Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID |
OS00546
|
|||||
| OS Name |
Light-activated phosphodiesterases
(LAPD)
|
[1], [2], [3] | ||||
|
Photoreceptor (PR) |
|
|||||
| Cofactor | Biliverdin (BV) | |||||
| Controlled Protein | Fusion protein | cGMP-dependent 3',5'-cyclic phosphodiesterase | ||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Mechanism of Action | Comformational change | [ 1] , [ 2] , [ 3] | ||||
| Controlled Signal Pathway | Hydrolysis cAMP/cGMP to interfere Ca2+ influx | |||||
| Effect | Inhibition | |||||
| Application | Optogenetic control cyclic sdenosine monophosphate (cAMP) in mammalian cells | |||||
| Note | No exogenous biliverdin was needed and LAPD could not be fully switched off by far-red light | |||||
| Light Information | Activation Wavelength | 670 nm | ||||
| Process | Reversible | |||||
| Deactivation Wavelength | 780 nm | |||||
| Activation Time | 10 s | |||||
| Deactivation Time | 10 s | |||||
| Light Intensity | 500 milliwatts per square centimeter | |||||
| Expression Information | Expression Method | Transfection | ||||
| Cell Lines | HEK-TM cells | |||||
| References |
|---|